Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.05)
# 2,777
Out of 4,827 analysts
198
Total ratings
24.06%
Success rate
-0.92%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.08 | +733.33% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.91 | +779.12% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $4.38 | +333.79% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.81 | +120.99% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $1.55 | +29.03% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $1.01 | +692.08% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $1.98 | +859.60% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.30 | +813.04% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.20 | +1,155.23% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $7 | $0.37 | +1,768.16% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.25 | +700.00% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.71 | +183.69% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $6.57 | +189.19% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $0.87 | +40,129.89% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.00 | +433.33% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.09 | +450.46% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.69 | +14,390.65% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.11 | +1,521.62% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.23 | +1,526.02% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $5.76 | +273,503.75% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $7.62 | +6,461.68% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | - | - | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.88 | +9,026.17% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $1.02 | +9,740.58% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.66 | +141,242.76% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.26 | +457.77% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.58 | +1,061.44% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.37 | +1,591.33% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.24 | +7,347.25% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.54 | +224.68% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | - | - | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $31.90 | -24.76% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.27 | +269,191.34% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.85 | +1,024,877.07% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.08
Upside: +733.33%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.91
Upside: +779.12%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $4.38
Upside: +333.79%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.81
Upside: +120.99%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.55
Upside: +29.03%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $1.01
Upside: +692.08%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $1.98
Upside: +859.60%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.30
Upside: +813.04%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.20
Upside: +1,155.23%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $7
Current: $0.37
Upside: +1,768.16%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.25
Upside: +700.00%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.71
Upside: +183.69%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $6.57
Upside: +189.19%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $0.87
Upside: +40,129.89%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.00
Upside: +433.33%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.09
Upside: +450.46%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.69
Upside: +14,390.65%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.11
Upside: +1,521.62%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.23
Upside: +1,526.02%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $5.76
Upside: +273,503.75%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $7.62
Upside: +6,461.68%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: -
Upside: -
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.88
Upside: +9,026.17%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $1.02
Upside: +9,740.58%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.66
Upside: +141,242.76%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.26
Upside: +457.77%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.58
Upside: +1,061.44%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.37
Upside: +1,591.33%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $0.24
Upside: +7,347.25%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $1.54
Upside: +224.68%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: -
Upside: -
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $31.90
Upside: -24.76%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.27
Upside: +269,191.34%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.85
Upside: +1,024,877.07%